Literature DB >> 9655144

Neoadjuvant chemotherapy for hypervascular malignant brain tumors of childhood.

A A Razzaq1, A R Cohen.   

Abstract

Some large hypervascular brain tumors pose an exceptional challenge to surgical resection, particularly in young children with small blood volumes. To limit blood loss during resection of hypervascular tumors, the authors used upfront chemotherapy as the primary treatment modality in 2 young children. This produced a dramatic reduction in tumor size and vascularity and greatly facilitated definitive surgical removal.

Entities:  

Mesh:

Year:  1997        PMID: 9655144     DOI: 10.1159/000121274

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  7 in total

1.  Medullary cistern choroid plexus papilloma.

Authors:  Vivek A Mehta; Chetan Bettegowda; Harvey S Singer; Edward S Ahn
Journal:  Childs Nerv Syst       Date:  2010-08-14       Impact factor: 1.475

Review 2.  Volumetric reduction of a choroid plexus carcinoma using preoperative chemotherapy.

Authors:  M M Souweidane; J H Johnson; E Lis
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

Review 3.  The therapy of infantile malignant brain tumors: current status?

Authors:  Chantal Kalifa; Jacques Grill
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

4.  Stereotactic radiosurgery for hypervascular intracranial tumors.

Authors:  Cheng-Chia Lee; Chun-Lung Chou; Ching-Jen Chen; Huai-Che Yang; Hsiu-Mei Wu; Cheng-Ying Shiau; David Hung-Chi Pan; Wen-Yuh Chung
Journal:  J Neurooncol       Date:  2018-08-20       Impact factor: 4.130

5.  Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected?

Authors:  Lorna K Fitzpatrick; Leslie J Aronson; Kenneth J Cohen
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  A French retrospective study on clinical outcome in 102 choroid plexus tumors in children.

Authors:  A Siegfried; S Morin; C Munzer; M B Delisle; M Gambart; S Puget; C A Maurage; C Miquel; C Dufour; P Leblond; N André; D Figarella Branger; J Kanold; J-L Kemeny; C Icher; A Vital; E Uro Coste; A I Bertozzi
Journal:  J Neurooncol       Date:  2017-07-04       Impact factor: 4.130

Review 7.  Rare primary central nervous system tumors.

Authors:  Charlotte Dai Kubicky; Arjun Sahgal; Eric L Chang; Simon S Lo
Journal:  Rare Tumors       Date:  2014-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.